AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15827359 — intervention group
Group type: COMPARATOR
Intervention: Expert videotape feedback
Number of subjects: 70
Study 15827359 — intervention group
Group type: EXPERIMENTAL
Intervention: All feedback groups
Number of subjects: 70
Study 15827359 — intervention group
Group type: COMPARATOR
Intervention: Nonfeedback group
Number of subjects: 70
Study 15827359 — intervention group
Group type: COMPARATOR
Intervention: All groups (feedback and nonfeedback)
Number of subjects: 70
Study 11818106 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 50 microg intra-vaginally
Number of subjects: 152
Study 10211492 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine injection
Number of subjects: 115
Study 8550362 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan 100 mg tid for 7 days
Number of subjects: 169
Study 8550362 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 169
Study 2775608 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous aminophylline
Number of subjects: 6
Study 2775608 — intervention group
Group type: COMPARATOR
Intervention: Baseline tremor power
Number of subjects: 6
Study 2775608 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma theophylline clearance
Number of subjects: 6
Study 2775608 — intervention group
Group type: EXPERIMENTAL
Intervention: t1/2 elimination
Number of subjects: 6
Study 2775608 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume of distribution
Number of subjects: 6
Study 339659 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 75 microgram twice daily
Number of subjects: 21
Study 339659 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 339659 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine and Placebo (combined analysis)
Number of subjects: 21
Study 31650795 — intervention group
Group type: EXPERIMENTAL
Intervention: β-caryophyllene (126 mg/day)
Number of subjects: 66
Study 31650795 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 29049901 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 48
Study 29049901 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 48
Study 29049901 — intervention group
Group type: COMPARATOR
Intervention: Aerobic exercise and Resistance training
Number of subjects: 48
Study 26350688 — intervention group
Group type: EXPERIMENTAL
Intervention: Target-Controlled Infusion (TCI)
Number of subjects: 100
Study 26350688 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard sedation)
Number of subjects: 100
Study 23685488 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) usage
Number of subjects: 30
Study 23685488 — intervention group
Group type: COMPARATOR
Intervention: Visually normal healthy subjects (control group)
Number of subjects: 30
Study 21831967 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi‐component interactive intervention including Web‐based continuing medical education, performance feedback and quality improvement tools
Number of subjects: 205
Study 21831967 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 205
Study 18355137 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubeless PCNL with Double‐J stent
Number of subjects: 60
Study 18355137 — intervention group
Group type: COMPARATOR
Intervention: PCNL with nephrostomy tube
Number of subjects: 60
Study 16854755 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc/clindamycin gel (Zindaclin 1%)
Number of subjects: 24
Study 16854755 — intervention group
Group type: COMPARATOR
Intervention: Clindamycin lotion (Dalacin T)
Number of subjects: 24
Study 14747124 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtration of cardiotomy suction blood during cardiopulmonary bypass with a fat removal filter (n=14)
Number of subjects: 28
Study 14747124 — intervention group
Group type: COMPARATOR
Intervention: Control patients without filtration (n=14)
Number of subjects: 28
Study 11170778 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrison Packs (2 x 1000 mL triple foil laminated pouches)
Number of subjects: 240
Study 11170778 — intervention group
Group type: COMPARATOR
Intervention: Ross Ready‐to‐Hang containers (2 x 1000 mL rigid plastic bottles)
Number of subjects: 240
Study 11170778 — intervention group
Group type: EXPERIMENTAL
Intervention: Giving sets from both systems
Number of subjects: 240
Study 11170778 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrient containers from both systems
Number of subjects: 240
Study 11170778 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient days
Number of subjects: 240
Study 9333394 — intervention group
Group type: EXPERIMENTAL
Intervention: Perforated plastic cap bandage
Number of subjects: 40
Study 9333394 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined mull bandage with perforated plastic cap
Number of subjects: 40
Study 8143833 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium 4 mg, administered four times daily for patients on inhaled corticosteroids and twice daily for those on bronchodilator alone.
Number of subjects: 719
Study 8143833 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 719
Study 8143833 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium
Number of subjects: 719
Study 3294350 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1446
Study 31009408 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive transitional care intervention
Number of subjects: 180
Study 31009408 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 180
Study 31134640 — intervention group
Group type: EXPERIMENTAL
Intervention: HMB complex (3 g HMB, 14 g arginine, and 14 g glutamine daily)
Number of subjects: 88
Study 31134640 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard nutrition therapy)
Number of subjects: 88
Study 31134640 — intervention group
Group type: EXPERIMENTAL
Intervention: HMB complex (in subgroup with sequential organ failure assessment scores <10)
Number of subjects: 88
Study 31134640 — intervention group
Group type: COMPARATOR
Intervention: Control group (in subgroup with sequential organ failure assessment scores <10)
Number of subjects: 88
Study 29385590 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-payment for consumer genomic testing (CGT)
Number of subjects: 2037
Study 29385590 — intervention group
Group type: COMPARATOR
Intervention: Fully subsidized testing
Number of subjects: 2037
Study 29385590 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-payment condition in online experiment
Number of subjects: 2037
Study 29385590 — intervention group
Group type: COMPARATOR
Intervention: Fully-subsidized condition in online experiment
Number of subjects: 2037
Study 28288041 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervarix
Number of subjects: 27
Study 28288041 — intervention group
Group type: EXPERIMENTAL
Intervention: Gardasil
Number of subjects: 27
Study 26317618 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel (60 mg loading and 10 mg maintenance dose)
Number of subjects: 44
Study 26317618 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (600 mg reloading and 150 mg maintenance dose)
Number of subjects: 44
Study 23358847 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency stenting followed by elective resection (ESER group)
Number of subjects: 60
Study 23358847 — intervention group
Group type: COMPARATOR
Intervention: Total abdominal colectomy and ileorectal anastomosis (TACIR group)
Number of subjects: 60
Study 23358847 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques (ESER and TACIR)
Number of subjects: 60
Study 23358847 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic stenting followed by elective resection (ESER group)
Number of subjects: 60
Study 21173304 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab (80 mg at week 0, then 40 mg every other week starting at week 1)
Number of subjects: 72
Study 21173304 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 21173304 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 72
Study 18464971 — intervention group
Group type: EXPERIMENTAL
Intervention: Allowing sutures to be wet and uncovered in the first 48 hours following minor excisions
Number of subjects: 0
Study 18464971 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 16537347 — intervention group
Group type: EXPERIMENTAL
Intervention: Free visibility aids (reflective and fluorescent slap wrap, reflective durable sticker, educational material)
Number of subjects: 377
Study 16537347 — intervention group
Group type: COMPARATOR
Intervention: Control group (no visibility aids provided)
Number of subjects: 377
Study 12902964 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation without traction
Number of subjects: 22
Study 12902964 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation with manual traction
Number of subjects: 22
Study 12902964 — intervention group
Group type: COMPARATOR
Intervention: Premanipulation radiograph and/or CT scan
Number of subjects: 22
Study 12902964 — intervention group
Group type: COMPARATOR
Intervention: Premanipulation plus traction radiograph and/or CT scan
Number of subjects: 22
Study 12902964 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmanipulation radiograph and/or CT scan
Number of subjects: 22
Study 12902964 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmanipulation plus traction radiograph and/or CT scan
Number of subjects: 22
Study 10988047 — intervention group
Group type: EXPERIMENTAL
Intervention: USPIO ferumoxtran-10 at a dose of 0.8 mg Fe/kg
Number of subjects: 99
Study 10988047 — intervention group
Group type: EXPERIMENTAL
Intervention: USPIO ferumoxtran-10 at a dose of 1.1 mg Fe/kg
Number of subjects: 99
Study 10988047 — intervention group
Group type: EXPERIMENTAL
Intervention: USPIO ferumoxtran-10 at a dose of 1.7 mg Fe/kg
Number of subjects: 99
Study 9526177 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy adult females during the luteal phase
Number of subjects: 0
Study 9526177 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients suffering from premenstrual syndrome or major depression during the luteal phase
Number of subjects: 0
Study 9526177 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients suffering from premenstrual syndrome or major depression during the follicular phase
Number of subjects: 0
Study 7692159 — intervention group
Group type: EXPERIMENTAL
Intervention: enalapril 20 mg/day
Number of subjects: 20
Study 7692159 — intervention group
Group type: EXPERIMENTAL
Intervention: atenolol 100 mg/day
Number of subjects: 20
Study 3095912 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diets
Number of subjects: 9
Study 3095912 — intervention group
Group type: COMPARATOR
Intervention: Medium-fat diet
Number of subjects: 9
Study 30701811 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with chronic hepatitis C with insulin resistance (HOMA index ≥2.77)
Number of subjects: 205
Study 30701811 — intervention group
Group type: COMPARATOR
Intervention: Patients with chronic hepatitis C without insulin resistance (HOMA index <2.77)
Number of subjects: 205
Study 30701811 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP indicators
Number of subjects: 205
Study 26017905 — intervention group
Group type: EXPERIMENTAL
Intervention: Jaimy(®)
Number of subjects: 14
Study 26017905 — intervention group
Group type: COMPARATOR
Intervention: Classic needle holder (NH)
Number of subjects: 14
Study 25697740 — intervention group
Group type: EXPERIMENTAL
Intervention: Frozen sushi
Number of subjects: 240
Study 25697740 — intervention group
Group type: COMPARATOR
Intervention: Unfrozen sushi
Number of subjects: 240
Study 23280545 — intervention group
Group type: EXPERIMENTAL
Intervention: Saffron (30 mg/daily)
Number of subjects: 38
Study 23280545 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 20625290 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineralocorticoid receptor blockers (MRBs) such as spironolactone or eplerenone, low doses added onto an angiotensin-converting enzyme inhibitor-based regimen
Number of subjects: 0
Study 20625290 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineralocorticoid receptor blockers (MRBs)
Number of subjects: 0
Study 20625290 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 18924005 — intervention group
Group type: EXPERIMENTAL
Intervention: aluminum hydroxide‐magnesium hydroxide (Maalox)
Number of subjects: 49
Study 18924005 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine gel
Number of subjects: 49
Study 18924005 — intervention group
Group type: EXPERIMENTAL
Intervention: baby shampoo
Number of subjects: 49
Study 18924005 — intervention group
Group type: EXPERIMENTAL
Intervention: milk
Number of subjects: 49
Study 18924005 — intervention group
Group type: EXPERIMENTAL
Intervention: water
Number of subjects: 49
Study 16149294 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate 2 g three times daily during radiotherapy
Number of subjects: 51
Study 16149294 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets during radiotherapy
Number of subjects: 51
Study 11975425 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil with 0.5 MAC desflurane (n = 15)
Number of subjects: 45
Study 11975425 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil with sevoflurane (n = 15)
Number of subjects: 45
Study 11975425 — intervention group
Group type: COMPARATOR
Intervention: Alfentanil with 1 MAC desflurane (n = 15)
Number of subjects: 45
Study 11975425 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 45
Study 10515237 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum thrombomodulin (TM) levels in nonsurvivors with DIC
Number of subjects: 0
Study 10515237 — intervention group
Group type: COMPARATOR
Intervention: Serum thrombomodulin (TM) levels in survivors with DIC
Number of subjects: 0
Study 10515237 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin degradation product (FDP) levels in nonsurvivors with DIC
Number of subjects: 0
Study 10515237 — intervention group
Group type: COMPARATOR
Intervention: Fibrin degradation product (FDP) levels in survivors with DIC
Number of subjects: 0
Study 8521122 — intervention group
Group type: COMPARATOR
Intervention: 12 mM NaF (F)
Number of subjects: 10
Study 8521122 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.55 mM CHX diacetate+F (F‐CHX)
Number of subjects: 10
Study 8521122 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mM Zn acetate+F (F‐Zn)
Number of subjects: 10
Study 8521122 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of F‐CHX‐Zn
Number of subjects: 10
Study 2140488 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane-based anesthetic
Number of subjects: 31
Study 2140488 — intervention group
Group type: COMPARATOR
Intervention: Alfentanil continuous infusion
Number of subjects: 31
Study 6996086 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 661
Study 6996086 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 661
Study 30376644 — intervention group
Group type: EXPERIMENTAL
Intervention: Pozik‐Bizi program
Number of subjects: 420
Study 30376644 — intervention group
Group type: COMPARATOR
Intervention: Play program
Number of subjects: 420
Study 27786520 — intervention group
Group type: EXPERIMENTAL
Intervention: Working overtime
Number of subjects: 182
Study 27786520 — intervention group
Group type: COMPARATOR
Intervention: Not working overtime
Number of subjects: 182
Study 26018970 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric training (ECC)
Number of subjects: 58
Study 26018970 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy slow resistance training (HSR)
Number of subjects: 58
Study 24838660 — intervention group
Group type: EXPERIMENTAL
Intervention: LigaSure
Number of subjects: 160
Study 24838660 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 160
Study 22954122 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 57
Study 22954122 — intervention group
Group type: EXPERIMENTAL
Intervention: Benazepril
Number of subjects: 57
Study 22954122 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 57
Study 22954122 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal blood pressure patients)
Number of subjects: 57
Study 18978503 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetyl-L-carnitine (ALC) 2 g/d
Number of subjects: 30
Study 18978503 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone + Acetyl-L-carnitine (ALC) in morphine-tolerant mice
Number of subjects: 30
Study 18978503 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 30
Study 17890354 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast-enhanced coronary CT angiography
Number of subjects: 53
Study 10728949 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest fibrinogen tertile
Number of subjects: 258
Study 10728949 — intervention group
Group type: COMPARATOR
Intervention: First tertile of fibrinogen
Number of subjects: 258
Study 10728949 — intervention group
Group type: COMPARATOR
Intervention: Second tertile of fibrinogen
Number of subjects: 258
Study 9046194 — intervention group
Group type: EXPERIMENTAL
Intervention: Tannic acid (20%) lotion
Number of subjects: 10
Study 9046194 — intervention group
Group type: COMPARATOR
Intervention: Iontophoresis
Number of subjects: 10
Study 1326339 — intervention group
Group type: EXPERIMENTAL
Intervention: ORG 2766 (20 mg per day during 4 weeks)
Number of subjects: 14
Study 4015388 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary closure
Number of subjects: 105
Study 4015388 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary closure with subcutaneous drains
Number of subjects: 105
Study 4015388 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed primary closure
Number of subjects: 105
Study 30994586 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-exercise pedaling protocol
Number of subjects: 60
Study 30994586 — intervention group
Group type: COMPARATOR
Intervention: 10-exercise, non-pedaling protocol
Number of subjects: 60
Study 29892041 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D (4000 IU/d) for 4 months
Number of subjects: 215
Study 29892041 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 215
Study 26988951 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued warfarin during surgery
Number of subjects: 659
Study 26988951 — intervention group
Group type: COMPARATOR
Intervention: No CSH (control group)
Number of subjects: 659
Study 26988951 — intervention group
Group type: EXPERIMENTAL
Intervention: CSH presence
Number of subjects: 659
Study 26988951 — intervention group
Group type: EXPERIMENTAL
Intervention: Empiric antibiotics upon development of hematoma
Number of subjects: 659
Study 25590926 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium pidolate (MgP)
Number of subjects: 90
Study 25590926 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 22753635 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 173
Study 22753635 — intervention group
Group type: COMPARATOR
Intervention: Brief education and support condition
Number of subjects: 173
Study 21092447 — intervention group
Group type: EXPERIMENTAL
Intervention: PAD (bortezomib + adriamycin + dexamethasone)
Number of subjects: 54
Study 21092447 — intervention group
Group type: COMPARATOR
Intervention: VAD (vincristine + adriamycin + dexamethasone)
Number of subjects: 54
Study 21092447 — intervention group
Group type: EXPERIMENTAL
Intervention: PAD
Number of subjects: 54
Study 21092447 — intervention group
Group type: COMPARATOR
Intervention: VAD
Number of subjects: 54
Study 21092447 — intervention group
Group type: COMPARATOR
Intervention: PAD and VAD
Number of subjects: 54
Study 18396717 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous free fat particle injection
Number of subjects: 41
Study 18396717 — intervention group
Group type: COMPARATOR
Intervention: Autologous free fat particle injection combined with bFGF (4,200 IU/10 mL)
Number of subjects: 41
Study 15810932 — intervention group
Group type: EXPERIMENTAL
Intervention: Information skills training for social-care practitioners and health-care librarians
Number of subjects: 23
Study 12878632 — intervention group
Group type: EXPERIMENTAL
Intervention: Alizapride 50 mg
Number of subjects: 84
Study 12878632 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide 10 mg
Number of subjects: 84
Study 10473769 — intervention group
Group type: EXPERIMENTAL
Intervention: Interhemispheric transfer during simple reaction time tasks
Number of subjects: 12
Study 8730885 — intervention group
Group type: EXPERIMENTAL
Intervention: Histochemical evaluation of placental angiotensinase A activity in pre-eclampsia
Number of subjects: 87
Study 8730885 — intervention group
Group type: EXPERIMENTAL
Intervention: Histochemical evaluation of placental angiotensinase A activity in pregnancy-induced hypertension
Number of subjects: 87
Study 8730885 — intervention group
Group type: EXPERIMENTAL
Intervention: Histochemical evaluation of placental angiotensinase A activity in uncomplicated pregnancies
Number of subjects: 87
Study 8730885 — intervention group
Group type: COMPARATOR
Intervention: Biochemical measurements of fetal blood vessels
Number of subjects: 87
Study 1680996 — intervention group
Group type: EXPERIMENTAL
Intervention: Trichlormethiazide (1 tab qd)
Number of subjects: 7
Study 1680996 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (1 tab qd)
Number of subjects: 7
Study 30063247 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol alone
Number of subjects: 102
Study 30063247 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol and subsequent vacuum aspiration
Number of subjects: 102
Study 30063247 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 102
Study 26758574 — intervention group
Group type: EXPERIMENTAL
Intervention: Saffron (1 g)
Number of subjects: 204
Study 26758574 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger (3 g)
Number of subjects: 204
Study 26758574 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinnamon (3 g)
Number of subjects: 204
Study 26758574 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardamom (3 g)
Number of subjects: 204
Study 26758574 — intervention group
Group type: COMPARATOR
Intervention: Control (3 glasses of tea without herbs)
Number of subjects: 204